NCT06309355

Topical YR001 Ointment in Adult With Mild to Moderate Atopic Dermatitis

A Randomized, Placebo-controlled, Double-blind, Multi Center, Phase IIa Trial Investigating the Safety, Tolerability, Pharmacokinetics and Efficacy of Topical Ointment YR001 in Adult Patients With Mild to Moderate Atopic Dermatitis

• Status: Completed
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 35 (actual)
• Sponsor: Hangzhou Yirui Pharmaceutical Technology Co., Ltd · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

This study is to evaluate the safety, tolerability, and pharmacokinetics of YR001 topical ointment in adult patients with mild to moderate atopic dermatitis

Conditions

• Atopic Dermatitis

Interventions

Type	Name	Description
DRUG	YR001 ointment	The intervention is YR001 ointment on a range of body surface area for multiple topical administration
OTHER	Placebo	The intervention is Placebo on a range of body surface area for multiple topical administration

Timeline

• Start date: 2024-06-19
• Primary completion: 2025-11-20
• Completion: 2025-11-20
• First posted: 2024-03-13
• Last updated: 2025-12-18

Locations

4 sites across 1 country: United States

Regulatory

• FDA-regulated drug study